Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "D05" (38)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Tars (D05AA) 6 products
WHO-DDD
IP
CI
Bitumol 20 %
30 g
PR
5.15
k.A.
Ointment: Ichthammolum 200 mg
Streuli Pharma AG
D
FB
G
IP
CI
Bitumol 20 %
1000 g
PR
PR
k.A.
Ointment: Ichthammolum 200 mg
Streuli Pharma AG
D
FB
G
IP
CI
Ichtholan 10% Zugsalbe
40 g
PR
9.10
k.A.
Ointment: Ichthammolum 100 mg
Merz Pharma (Schweiz) AG
D
FB
G
IP
CI
Ichtholan 20% Zugsalbe
40 g
PR
11.70
k.A.
Ointment: Ichthammolum 200 mg
Merz Pharma (Schweiz) AG
D
FB
G
IP
CI
Ichtholan 50% Zugsalbe
40 g
PR
13.80
k.A.
Ointment: Ichthammolum 500 mg
Merz Pharma (Schweiz) AG
D
FB
G
IP
CI
Leucen
30 g
PR
12.70
k.A.
Ointment: 9 Active Agents
Tentan AG
D
FB
G
Calcitriol (D05AX03) 2 products
WHO-DDD
DrugBank.ca
IP
CI
Silkis
30 g
14.19
28.60
k.A.
Ointment: Calcitriolum 3 µg
Galderma SA
B
FB
G
IP
CI
Silkis
100 g
35.94
57.65
k.A.
Ointment: Calcitriolum 3 µg
Galderma SA
B
FB
G
Tacalcitol (D05AX04) 4 products
WHO-DDD
IP
CI
Curatoderm
60 g
33.59
52.95
10 %
Ointment: Tacalcitolum Monohydricum 4.17 µg
Almirall AG
B / SL
FB
G
IP
CI
Curatoderm Lotion
50 ml
20.55
38.75
10 %
Lotion: Tacalcitolum Monohydricum 4.17 µg/g
Almirall AG
B / SL
FB
G
IP
CI
Curatoderm
20 g
14.44
28.90
k.A.
Ointment: Tacalcitolum Monohydricum 4.17 µg
Almirall AG
B
FB
G
IP
CI
Curatoderm Lotion
20 ml
11.25
25.20
k.A.
Lotion: Tacalcitolum Monohydricum 4.17 µg/g
Almirall AG
B
FB
G
Calcipotriol, Combinations (D05AX52) 17 products
WHO-DDD
DrugBank.ca
IP
CI
CRYSALIS Leman
30 g
15.50
33.35
10 %
Ointment: 2 Active Agents
Leman SKL SA
B / SL / SG
FB
G
IP
CI
CRYSALIS Leman
60 g
27.25
46.25
10 %
Ointment: 2 Active Agents
Leman SKL SA
B / SL / SG
FB
G
IP
CI
CRYSALIS Leman
2 x 60 g
45.45
65.85
10 %
Ointment: 2 Active Agents
Leman SKL SA
B / SL / SG
FB
G
L
IP
CI
Wynzora 50 μg/g + 0.5
mg/g
60 g
39.33
58.65
10 %
Cream: 2 Active Agents
Almirall AG
B / SL
FB
G
L
IP
CI
Wynzora 50 μg/g + 0.5
mg/g
120 g
69.22
90.25
10 %
Cream: 2 Active Agents
Almirall AG
B / SL
FB
G
IP
CI
Daivobet
30 g
21.14
39.15
10 %
Ointment: 2 Active Agents
LEO Pharmaceutical
Products Sarath Ltd.
B / SL / SO
FB
G
IP
CI
Daivobet
60 g
37.19
56.45
10 %
Ointment: 2 Active Agents
LEO Pharmaceutical
Products Sarath Ltd.
B / SL / SO
FB
G
IP
CI
Calcipotriol-Betamethason-
Mepha
30 g
17.98
35.90
10 %
Ointment: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Calcipotriol-Betamethason-
Mepha
60 g
31.61
50.70
10 %
Ointment: 2 Active Agents
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Psotriol
30 g
16.86
34.75
10 %
Ointment: 2 Active Agents
Dermapharm AG
B / SL / SG
FB
G
IP
CI
Psotriol
60 g
31.61
50.70
10 %
Ointment: 2 Active Agents
Dermapharm AG
B / SL / SG
FB
G
IP
CI
Daivobet
60 g
32.80
51.95
10 %
Gel: 2 Active Agents
LEO Pharmaceutical
Products Sarath Ltd.
B / SL
FB
G
IP
CI
Daivobet
2 x 60 g
57.74
78.45
10 %
Gel: 2 Active Agents
LEO Pharmaceutical
Products Sarath Ltd.
B / SL
FB
G
IP
CI
Xamiol
30 g
19.66
37.60
10 %
Gel: 2 Active Agents
LEO Pharmaceutical
Products Sarath Ltd.
B / SL
FB
G
IP
CI
Xamiol
60 g
34.59
53.75
10 %
Gel: 2 Active Agents
LEO Pharmaceutical
Products Sarath Ltd.
B / SL
FB
G
L
IP
CI
Enstilar
60 g
46.67
66.55
10 %
Schaum zur Anwendung auf der Haut: 2 Active Agents
LEO Pharmaceutical
Products Sarath Ltd.
B / SL
FB
G
IP
CI
Calcipotriol-Betamethason-
Mepha
120 g
PR
PR
k.A.
Ointment: 2 Active Agents
Mepha Pharma AG
B
FB
G
Antipsoriatics for Systemic Use (D05B) 1 products
WHO-DDD
CI
H
Dr. Reckeweg R 65
Psoriasin
50 ml
PR
PR
k.A.
gouttes buvables: 4 Active Agents
Laboratoire Jacques
Reboh et fils SA
D
FB
G
Acitretin (D05BB02) 8 products
WHO-DDD
DrugBank.ca
L
IP
CI
Neotigason 10 mg
30 Capsule(s)
28.80
47.30
10 %
Capsules: Acitretinum 10 mg
Teva Pharma AG
A / SL / SO
FB
G
L
IP
CI
Neotigason 10 mg
100 Capsule(s)
90.70
114.10
10 %
Capsules: Acitretinum 10 mg
Teva Pharma AG
A / SL / SO
FB
G
L
IP
CI
Neotigason 25 mg
30 Capsule(s)
60.50
81.50
10 %
Capsules: Acitretinum 25 mg
Teva Pharma AG
A / SL / SO
FB
G
L
IP
CI
Neotigason 25 mg
100 Capsule(s)
183.30
214.05
10 %
Capsules: Acitretinum 25 mg
Teva Pharma AG
A / SL / SO
FB
G
L
IP
CI
Acicutan 10 mg
30 Capsule(s)
21.88
40.20
10 %
Capsules: Acitretinum 10 mg
Dermapharm AG
A / SL / SG
FB
G
L
IP
CI
Acicutan 10 mg
100 Capsule(s)
75.45
98.45
10 %
Capsules: Acitretinum 10 mg
Dermapharm AG
A / SL / SG
FB
G
L
IP
CI
Acicutan 25 mg
30 Capsule(s)
48.67
69.35
10 %
Capsules: Acitretinum 25 mg
Dermapharm AG
A / SL / SG
FB
G
L
IP
CI
Acicutan 25 mg
100 Capsule(s)
155.81
185.85
10 %
Capsules: Acitretinum 25 mg
Dermapharm AG
A / SL / SG
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home